Emergent Biosolutions Inc. (EBS)
Emergent BioSolutions to Participate in Upcoming Investor Conferences
NRx Pharmaceuticals Inc (NRXP)
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
DaVita HealthCare Partners Inc (DVA)
DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care
Recursion Pharmaceuticals Inc (RXRX)
Recursion to Participate in Upcoming Investor Conferences
Lucid Diagnostics Inc. (LUCD)
Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025
PAVmed Inc (PAVMZ)
Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025
Protara Therapeutics Inc. (TARA)
Protara Therapeutics to Participate in Upcoming Investor Conferences
Vor Biopharma Inc (VOR)
Telitacicept Achieved Primary Endpoint in Phase 3 Clinical Study for IgA Nephropathy
Allarity Therapeutics Inc. (ALLR)
Axogen Inc. (AXGN)
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
MiMedx Group Inc (MDXG)
MIMEDX to Participate in Upcoming Investor Conferences
CNS Pharmaceuticals Inc. (CNSP)
CNS Pharmaceuticals - New Press Release
Astria Therapeutics Inc. (ATXS)
Astria Therapeutics to Present at Upcoming Cantor Global Healthcare Conference
Elutia Inc (ELUT)
Elutia to Participate in Upcoming Investor Conferences
Design Therapeutics Inc (DSGN)
Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference